Activation and inhibition of kidney CLC-K chloride channels by fenamates

Molecular Pharmacology

Volumn 69, Issue 1, 2006, Pages 165-173

  Liantonio, Antonella ^a   Picollo, Alessandra ^b   Babini, Elena ^b   Carbonara, Giuseppe ^a   Fracchiolla, Giuseppe ^a   Loiodice, Fulvio ^a   Tortorella, Vincenzo ^a   Pusch, Michael ^b   Camerino, Diana Conte ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; DIURETIC AGENT; FENAMIC ACID DERIVATIVE; FLUFENAMIC ACID; NIFLUMIC ACID;

ANIMAL CELL; ARTICLE; BARTTER SYNDROME; BINDING SITE; CHLORIDE CONDUCTANCE; CHLORIDE CURRENT; CONTROLLED STUDY; DRUG IDENTIFICATION; FEMALE; INHIBITION KINETICS; KIDNEY; MOLECULE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANIMALS; ANTHRANILIC ACIDS; BARTTER SYNDROME; CHLORIDE CHANNELS; KIDNEY; XENOPUS LAEVIS;

EID: 30044450910     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.017384     Document Type: Article

References (27)

1. Akizuki N, Uchida S, Sasaki S, and Marumo F (2001) Impaired solute accumulation in inner medulla of CLCNK1 -/- mice kidney. Am J Physiol 280:F79-F87.
2. Birkenhäger R, Otto E, Schurmann MJ, Vollmer M, Ruf E-M, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, et al. (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29:310-314.
3. Dhanaraj V and Vijayan M (1988) Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study. Acta Crystallogr B 44:406-412.
4. Estévez R, Boettger T, Stein V, Birkenhäger R, Otto E, Hildebrandt F, and Jentsch TJ (2001) Barttin is a Cl channel beta-subunit crucial for renal Cl reabsorption and inner ear K secretion. Nature (Lond) 414:558-561.
5. Fong P (2004) CLC-K channels: if the drug fits, use it. EMBO (Eur Mol Biol Organ) Rep 5:565-566.
6. Fujiwara H and Kitagawa K (2000) Synthesis of pyridopyranoquinolines by the Skraup reaction of amino-5H-benzopyrano[2,3-b]pyridine-5-ones. Heterocycles 53:409-417.
7. Jeck N, Waldegger P, Doroszewicz J, Seyberth H, and Waldegger S (2004a) A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity. Kidney Int 65:190-197.
8. Jeck N, Waldegger S, Lampert A, Boehmer C, Waldegger P, Lang PA, Wissinger B, Friedrich B, Risler T, Moehle R, et al. (2004b) Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 43:1175-1181.
9. Jentsch TJ (2005) Chloride transport in the kidney: lessons from human disease and knockout mice. J Am Soc Nephrol 16:1549-1561.
10. Jentsch TJ, Stein V, Weinreich F, and Zdebik AA (2002) Molecular structure and physiological function of chloride channels. Physiol Rev 82:503-568.
11. Kieferle S, Fong P, Bens M, Vandewalle A, and Jentsch TJ (1994) Two highly homologous members of the ClC chloride channel family in both rat and human kidney. Proc Natl Acad Sci USA 91:6943-6947.
12. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H, Naraba H, and Tomoike H (2005) Association analysis between hypertension and CYBA, CLCNKB and KCNMB1 functional polymorphisms in the Japanese population-the Suita Study. Circ J 69:138-142.
13. Kong J, White CA, Krylov AI, Sherrill CD, Adamson RD, Furlani TR, Lee MS, Lee AM, Gwaltney SR, Adams TR, et al. (2000) Q-Chem 2.0: a high-performance ab initio electronic structure program package. J Computational Chem 21:1532-1548.
14. Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A, et al. (2002) Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxyalkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Mol Pharmacol 62:265-271.
15. Liantonio A, Pusch M, Picollo A, Guida P, De Luca A, Pierno S, Fracchiolla G, Loiodice F, Tortorella P, and Conte Camerino D (2004) Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers. J Am Soc Nephrol 15:13-20.
16. Picollo A, Liantonio A, Didonna MP, Elia L, Camerino DC, and Pusch M (2004) Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO (Eur Mol Biol Organ) Rep 5:584-589.
17. Pusch M, Liantonio A, Bertorello L, Accardi A, De Luca A, Pierno S, Tortorella V, and Conte Camerino D (2000) Pharmacological characterization of the chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol Pharmacol 58:498-507.
18. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nusing RM, Seyberth HW, and Komhoff M (2002) Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 62:253-260.
19. Schlingmann KP, Konrad M, Jeck N, Waldegger P, Reinalter SC, Holder M, Seyberth HW, and Waldegger S (2004) Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 350:1314-1319.
20. Sherlock MH, Kaminski JJ, Tom WC, Lee JF, Wong S-C, Kreutner W, Bryant RW, and McPhail AT (1988) Antiallergy agents. 1. Substituted 1,8-naphthyridin-2(1H)-ones as inhibitors of SRS-A release. J Med Chem 31:2108-2121.
21. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alay H, Bakkaloglu A, et al. (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17:171-178.
22. Speirs HJ, Wang WY, Benjafield AV, and Morris BJ (2005) No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36. J Hyperten 23:1491-1496.
23. Uchida S and Sasaki S (2005) Function of chloride channels in the kidney. Annu Rev Physiol 67:759-778.
24. Uchida S, Sasaki S, Nitta K, Uchida K, Horita S, Nihei H, and Marumo F (1995) Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1. J Clin Investig 95:104-113.
25. Vandewalle A, Cluzeaud F, Bens M, Kieferle S, Steinmeyer K, and Jentsch TJ (1997) Localization and induction by dehydration of ClC-K chloride channels in the rat kidney. Am J Physiol 272:F678-F688.
26. Villani FJ, Mann TA, Wefer EA, Hannon J, Larca LL, Landon MJ, Spivak W, Vashi D, Tozzi S, Danko G, et al. (1975) Benzopyranopyridine derivatives. 1. Aminoalkyl derivatives of the azaxanthenes as bronchodilating agents. J Med Chem 18:1-8.
27. Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, and Seyberth HW (2002) Barttin increases surface expression and changes current properties of CLC-K channels. Pfleug Arch Eur J Phsyiol 444:411-418.